Aummune
PrivateCompany Overview
Aummune operates in Healthcare & Life Sciences and is based in Tel Aviv. It was founded in 2017.
Aummune is a biotechnology company that develops individualized oligonucleotide-based immunotherapies for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aummune Comparables
Compare Aummune with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Imvax | 83% | |
| Aptabridge Therapeutics | 79% | |
| Scopus BioPharma Inc. | 76% |
For institutional investors. Book with your work email.
Aummune Funding Rounds
Historical fundraising activity
Aummune Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aummune's valuation, stock price, and market status.
Is Aummune a public or private company?
Aummune is a private company.
What is the current stock price of Aummune?
Aummune is a private company, so its shares have no public market price. Caplight tracks Aummune's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aummune worth (valuation)?
Valuation information for Aummune is not publicly available.
Can I buy Aummune stock?
Aummune shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aummune's last funding round?
Funding round information for Aummune is not publicly available.
Who are the main investors in Aummune?
Investor information for Aummune is not publicly disclosed.
Will Aummune IPO soon?
No public IPO plans have been announced for Aummune.
How can I track Aummune secondary market activity?
Caplight tracks bids, offers, and trades in Aummune's shares on secondary markets.